Your browser doesn't support javascript.
loading
Clinical response to omalizumab in patients with hereditary α-tryptasemia.
Mendoza Alvarez, Lybil B; Barker, Russell; Nelson, Celeste; DiMaggio, Tom; Stone, Kelly D; Milner, Joshua D; Rosenthal, Jamie A; Petroni, Daniel H; Glover, Sara C; Lyons, Jonathan J.
Afiliação
  • Mendoza Alvarez LB; Department of Medicine and Pediatrics University of Florida Gainesville, Florida.
  • Barker R; Department of Immunology Auckland Hospital, Auckland, New Zealand.
  • Nelson C; Laboratory of Allergic Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, Bethesda, Maryland.
  • DiMaggio T; Laboratory of Allergic Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, Bethesda, Maryland.
  • Stone KD; Laboratory of Allergic Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, Bethesda, Maryland.
  • Milner JD; Laboratory of Allergic Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, Bethesda, Maryland.
  • Rosenthal JA; Division of Allergy and Infectious Diseases University of Washington Seattle, Washington.
  • Petroni DH; Northwest Asthma & Allergy Center Seattle, Washington.
  • Glover SC; Division of Digestive Diseases University of Mississippi Medical Center Jackson, Mississippi. Electronic address: scglover@umc.edu.
  • Lyons JJ; Laboratory of Allergic Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health, Bethesda, Maryland. Electronic address: jonathan.lyons@nih.gov.
Ann Allergy Asthma Immunol ; 124(1): 99-100.e1, 2020 01.
Article em En | MEDLINE | ID: mdl-31605754

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prurido / Urticária / Mastocitose / Antialérgicos / Triptases / Omalizumab Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prurido / Urticária / Mastocitose / Antialérgicos / Triptases / Omalizumab Idioma: En Ano de publicação: 2020 Tipo de documento: Article